Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Coltoff

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|December 15, 2022
Leukocytosis and MPNs: Where do we stand?Alexander Coltoff
The Lancet. Haematology|May 25, 2024
Striking the right balanceAlexander Coltoff
Leukemia Research|April 13, 2019
Relevant updates in systemic mastocytosisAlexander Coltoff, John Mascarenhas
Leukemia & Lymphoma|May 13, 2024
Emerging drug profile: JAK inhibitorsAlexander Coltoff, Andrew Kuykendall
Blood Advances|February 14, 2025
Fedratinib in 2025 and beyond: indications and future applicationsAlexander Coltoff, John Mascarenhas
Hematology/Oncology and Stem Cell Therapy|July 22, 2018
Romiplostim for thrombocytopenia following allogeneic stem cell transplantation: A case seriesGuido Lancman, Alexander Coltoff, Amir Steinberg
Hematological Oncology|March 26, 2018
Ruxolitinib for steroid-refractory graft-versus-host disease: A case seriesGuido Lancman, Alexander Coltoff, Amir Steinberg
Hematology/Oncology and Stem Cell Therapy|January 4, 2019
A single-institution experience of performing bloodless transplant in Jehovah's Witness patientsAlexander Coltoff, Aditya Shreenivas, Solmaz Afshar, et al.
Bone Marrow Transplantation|January 27, 2018
Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host diseaseAlexander Coltoff, Guido Lancman, Sara Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 23, 2021
Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based TherapyAlexander Coltoff, Andrew Bomback, Shayan Shirazian, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|December 15, 2022
Leukocytosis and MPNs: Where do we stand?Alexander Coltoff
The Lancet. Haematology|May 25, 2024
Striking the right balanceAlexander Coltoff
Leukemia Research|April 13, 2019
Relevant updates in systemic mastocytosisAlexander Coltoff, John Mascarenhas
Leukemia & Lymphoma|May 13, 2024
Emerging drug profile: JAK inhibitorsAlexander Coltoff, Andrew Kuykendall
Blood Advances|February 14, 2025
Fedratinib in 2025 and beyond: indications and future applicationsAlexander Coltoff, John Mascarenhas
Hematology/Oncology and Stem Cell Therapy|July 22, 2018
Romiplostim for thrombocytopenia following allogeneic stem cell transplantation: A case seriesGuido Lancman, Alexander Coltoff, Amir Steinberg
Hematological Oncology|March 26, 2018
Ruxolitinib for steroid-refractory graft-versus-host disease: A case seriesGuido Lancman, Alexander Coltoff, Amir Steinberg
Hematology/Oncology and Stem Cell Therapy|January 4, 2019
A single-institution experience of performing bloodless transplant in Jehovah's Witness patientsAlexander Coltoff, Aditya Shreenivas, Solmaz Afshar, et al.
Bone Marrow Transplantation|January 27, 2018
Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host diseaseAlexander Coltoff, Guido Lancman, Sara Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 23, 2021
Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based TherapyAlexander Coltoff, Andrew Bomback, Shayan Shirazian, et al.
Pageof 3